Educating orally anticoagulated patients in drug safety: A cluster-randomized study in general practice;Schulung oral antikoagulierter Patienten zur Arzneimitteltherapiesicherheit: Eine Cluster-randomisierte Studie in Hausarztpraxen

Deutsches Arzteblatt International

Volumn 111, Issue 37, 2014, Pages 607-614

  Vormfelde, Stefan Viktor ^a   Abu Abed, Manar ^a   Hua, Thanh Duc ^a   Schneider, Simon ^a   Friede, Tim ^a   Chenot, Jean François ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; PHENPROCOUMON;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DIET RESTRICTION; DRUG SAFETY; EPISTAXIS; FEMALE; GENERAL PRACTICE; HEMATOMA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; TREATMENT OUTCOME; CLUSTER ANALYSIS; CONSUMER HEALTH INFORMATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GERMANY; HEALTH LITERACY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PREVALENCE; PROCEDURES; RISK FACTOR; SAFETY; STATISTICS AND NUMERICAL DATA;

ADMINISTRATION, ORAL; ANTICOAGULANTS; CLUSTER ANALYSIS; CONSUMER HEALTH INFORMATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GENERAL PRACTICE; GERMANY; HEALTH LITERACY; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PREVALENCE; RISK FACTORS; SAFETY MANAGEMENT;

EID: 84907509143     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2014.0607     Document Type: Article

References (31)

1. Schwabe U, Paffrath D: Arzneiverordnungsreport 2012. Berlin, Heidelberg: Springer Medizin Verlag 2012.
2. You JJ, Singer DE, Howard PA, et al.: Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e531S-75S.
3. Kearon C, Akl EA, Comerota AJ, et al.: Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e419S-94S.
4. Camm AJ, Lip GY, De Caterina R, et al.: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719-47.
5. Vahanian A, Alfieri O, Andreotti F, et al.: Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012; 42: S1-44.
6. Hart RG, Tonarelli SB, Pearce LA: Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 2005; 36: 1588-93.
7. Torn M, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR: Risks of oral anticoagulant therapy with increasing age. Arch Intern Med 2005; 165: 1527-32.
8. Shoeb M, Fang MC: Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis 2013; 35: 312-9.
9. Kagansky N, Knobler H, Rimon E, Ozer Z, Levy S: Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med 2004; 164: 2044-50
10. York M, Agarwal A, Ezekowitz M: Physicians' attitudes and the use of oral anticoagulants: surveying the present and envisioning future. J Thromb Thrombolysis 2003; 16: 33-7.
11. Sawicki PT: A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 1999; 281: 145-50
12. Wong PY, Schulman S, Woodworth S, Holbrook A: Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis. J Thrombosis Haemost 2013; 11: 491-502.
13. Wofford JL, Wells MD, Singh S: Best strategies for patient education about anticoagulation with warfarin: a systematic review. BMC Health Serv Res 2008; 8: 40
14. Siebenhofer A, Jeitler K, Horvath K, Habacher W, Schmidt L, Semlitsch T: Self-management of oral anticoagulation. Dtsch Arztebl Int 2014; 111: 83-91.
15. Hua TD, Vormfelde SV, Abu Abed M, et al.: Practice nursed-based, individual and video-assisted patient education in oral anticoagulation - protocol of a cluster-randomized controlled trial. BMC Fam Pract 2011; 12: 17.
16. Chenot JF, Vormfelde SV: Gerinnungshemmer, Phenprocoumon - Was sollte ich darüber wissen? www.youtube.com/watch?v=F0uHbcOnReQ.
17. Hua TD, Abu Abed M, Vormfelde S, Chenot JF: Schulungsmaterialien. www.allgemeinmedizin.med.uni-goettingen.de/de/content/forschung/105.html (last accessed on 30. June 2014).
18. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E: A method to determine the optimal intensity of oral anticoagulant therapy. Thrombosis and haemostasis 1993; 69: 236-9.
19. Jank S, Bertsche T, Herzog W, Haefeli WE. Patient knowledge on oral anticoagulants: results of a questionnaire survey in Germany and comparison with the literature. Int J Clin Pharmacol Ther. 2008; 46: 280-8.
20. Winans ARM, Rudd KM, TrillerD. Assessing anticoagulation knowledge in patients new to warfarin therapy. Ann Pharmacother 2010; 44: 1152-7.
21. Nicolson D, Knapp P, Raynor DK, Spoor P. Written information about individual medicines for consumers. Cochrane Database Syst Rev 2009;(2):CD002104. doi: 10,1002/14651858.CD002104.pub3.
22. Ciciriello S, Johnston RV, Osborne RH, Wicks I, deKroo T, Clerehan R, O'Neill C, Buchbinder R. Multimedia educational interventions for consumers about prescribed and over-the-counter medications. Cochrane Database Syst Rev 2013;4:CD008416. doi: 10,1002/14651858.CD008416.pub2.
23. Verhoef TI, Ragia G, de Boer A, et al.: A randomized trial of genotypeguided dosing of acenocoumarol and phenprocoumon. N Engl J Med 2013; 369: 2304-12.
24. Pirmohamed M, Burnside G, Eriksson N, et al.: A randomized trial of genotype-guided dosing of warfarin. N Engl J Med 2013; 369: 2294-303.
25. Kimmel SE, French B, Kasner SE, et al.: A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med 2013; 369: 2283-93.
26. Siebenhofer A, Rakovac I, Kleespies C, Piso B, Didjurgeit U: Selfmanagement of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thromb Haemostas 2007; 97: 408-16.
27. Furie B: Do pharmacogenetics have a role in the dosing of vitamin K antagonists? N Engl J Med. 2013; 369: 2345-6.
28. Arzneimittelkommission der deutschen Ärzteschaft: Leitfaden: Orale Antikoagulation bei nicht valvulärem Vorhofflimmern. www.akdae.de/Arzneimitteltherapie/TE/LF/ (last accessed on 30. June 2014).
29. Pfeilschifter W, Luger S, Brunkhorst R, Lindhoff-Last E, Foerch C: The gap between trial data and clinical practice - an analysis of case reports on bleeding complications occurring under dabigatran and rivaroxaban anticoagulation. Cerebrovasc Dis 2013; 36: 115-9.
30. Gallego P, Roldan V, Lip GY: Novel oral anticoagulants in cardiovascular disease. J Cardiovasc Pharmacol Ther 2014; 19: 34-44.
31. Campbell MK, Piaggio G, Elbourne DR, Altman DG, Group C: Consort 2010 statement: extension to cluster randomised trials. BMJ 2012; 345: e5661.